Abiopharma

New Form S-8 POS - Verve Therapeutics, Inc. Filed: 2025-07-25 AccNo: 0001193125-25-165135 Size: 24 KB

New Form S-8 POS - Verve Therapeutics, Inc. Filed: 2025-07-25 AccNo: 0001193125-25-165134 Size: 24 KB

FDA approve AVATROMBOPAG

FDA approve AMLODIPINE

New Form S-8 POS - Verve Therapeutics, Inc. Filed: 2025-07-25 AccNo: 0001193125-25-165127 Size: 24 KB

New Form S-8 POS - Verve Therapeutics, Inc. Filed: 2025-07-25 AccNo: 0001193125-25-165125 Size: 24 KB

New Form S-8 POS - Verve Therapeutics, Inc. Filed: 2025-07-25 AccNo: 0001193125-25-165124 Size: 24 KB

New Form 6-K - Evaxion A/S Filed: 2025-07-25 AccNo: 0001171843-25-004705 Size: 17 KB

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

New Form PRE 14A - Vaxart, Inc. Filed: 2025-07-24 AccNo: 0001437749-25-023418 Size: 589 KB

New Form PRE 14A - Acurx Pharmaceuticals, Inc. Filed: 2025-07-24 AccNo: 0001104659-25-070373 Size: 772 KB

New Form DEF 14A - MSP Recovery, Inc. Filed: 2025-07-24 AccNo: 0000950170-25-098330 Size: 3 MB

FDA approve OZANIMOD

FDA approve CABOZANTINIB

FDA approve SITAGLIPTIN PHOSPHATE